Performance analysis of LakeShore Biopharma (LSB)
Annual Return
Over the past 3 years, LSB has had an average annual return of -23.19%, underperforming the benchmark SPY, which returned +19.63% annual.
Since Mar 16, 2023, LSB has had an average annual return of -59.55%, underperforming the benchmark SPY, which returned +22.54% annual.
| 2026 | 2025 | 2024 | 2023 | ||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|
| +0% | -81.89% | +577.35% | -96.07% |
Monthly Return
| Year | Jan | Feb | Mar | Apr | May | Jun | Jul | Aug | Sep | Oct | Nov | Dec | Annually Total |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 2026 | +0% | +0% | +0% | +0% | +0% | +0% | +0% | ||||||
| 2025 | -25.17% | -12.95% | +8.71% | -51.03% | -10.83% | -4.62% | -19.62% | -2.54% | -21.63% | -81.89% | |||
| 2024 | -22.14% | -4.58% | +89.73% | -2.17% | +18.45% | -22.43% | -30.52% | -1.73% | +54.41% | +241.33% | +18.02% | +25.86% | +577.35% |
| 2023 | -87.69% | +23.07% | -23.30% | -8.61% | +2.82% | -16.21% | -32.79% | -45.04% | +27.51% | -8.82% | -96.07% |
Drawdown analysis of LakeShore Biopharma (LSB)
The maximum drawdown for the LSB was -97.15%, occurring on Feb 2, 2024. This drawdown has not yet recovered.
The current LSB drawdown is -95.18%.
Since Mar 16, 2023 LSB has experienced the following drawdowns:
- 50% or more: 1 time
- 40% or more: 1 time
- 30% or more: 1 time
- 20% or more: 1 time
- 10% or more: 1 time
| Depth | Start | To Bottom | Bottom | To Recover | End | Total |
|---|---|---|---|---|---|---|
| -97.15% | Mar 16, 2023 | 222 | Feb 2, 2024 | Ongoing | Ongoing | Ongoing |